|
In8bio ، Inc. (INAB) تقييم DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
IN8bio, Inc. (INAB) Bundle
تبسيط التقييم In8bio ، Inc. (INAB) مع هذه الآلة الحاسبة DCF القابلة للتخصيص! يضم REAL In8bio ، Inc. (INAB) والمدخلات المتوقعة القابلة للتعديل ، يمكنك اختبار السيناريوهات والكشف عن القيمة العادلة In8bio ، Inc. (INAB) في دقائق.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA | -5.0 | -8.5 | -14.4 | -27.4 | -28.5 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Depreciation | .1 | .1 | .3 | 1.1 | 1.8 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -5.1 | -8.6 | -14.7 | -28.5 | -30.3 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Total Cash | .6 | 18.0 | 37.0 | 18.2 | 21.3 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Accounts Payable | .6 | .6 | .4 | 2.1 | .9 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Capital Expenditure | -.3 | .0 | -.3 | -3.7 | -.6 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 0 | 0 | 0 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -5.1 | -8.6 | -14.7 | -27.4 | -30.3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -4.8 | -8.4 | -14.9 | -28.3 | -30.3 | -.9 | .0 | .0 | .0 | .0 |
| WACC, % | 4.62 | 4.62 | 4.62 | 4.56 | 4.62 | 4.6 | 4.6 | 4.6 | 4.6 | 4.6 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.9 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -16 | |||||||||
| Equity Value | 16 | |||||||||
| Diluted Shares Outstanding, MM | 30 | |||||||||
| Equity Value Per Share | 0.52 |
What You Will Get
- Real INAB Financial Data: Pre-filled with IN8bio’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See IN8bio’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive INAB Data: Pre-loaded with IN8bio's historical financial performance and future projections.
- Customizable Financial Inputs: Modify revenue growth rates, profit margins, discount rates, tax assumptions, and capital investment figures.
- Interactive Valuation Model: Instant recalculations of Net Present Value (NPV) and intrinsic value based on user-defined parameters.
- Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate differing valuation results.
- Intuitive User Interface: Clean, organized layout suitable for both seasoned professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review IN8bio, Inc.'s pre-filled financial data and forecasts.
- Step 3: Modify critical inputs like revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Watch the DCF model update instantly as you tweak assumptions.
- Step 5: Analyze the outputs and use the results for investment decisions.
Why Choose the IN8bio, Inc. (INAB) Calculator?
- Accuracy: Utilizes real IN8bio financial data for precise calculations.
- Flexibility: Tailored for users to easily test and adjust inputs as needed.
- Time-Saving: Eliminate the tedious process of creating a financial model from the ground up.
- Professional-Grade: Crafted with the expertise and usability expected at the CFO level.
- User-Friendly: Intuitive design makes it accessible for users without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Evaluate IN8bio, Inc. (INAB) to make informed decisions on buying or selling shares.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts for IN8bio, Inc. (INAB).
- Startup Founders: Discover valuation strategies by examining how companies like IN8bio, Inc. (INAB) are assessed.
- Consultants: Create detailed valuation reports for clients based on insights from IN8bio, Inc. (INAB).
- Students and Educators: Utilize current data from IN8bio, Inc. (INAB) to enhance learning and teaching of valuation principles.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled IN8bio, Inc. (INAB) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for IN8bio, Inc. (INAB).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.